Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT06997458
Eligibility Criteria:
Inclusion Criteria:
General criteria:
* More than 18 years old
* Both genders
* Ability to provide written informed consent
Specific criteria:
* NSCLC
* Patients diagnosed with the 8th Edition of the Tumor, Node, Metastasis (TNM) staging system for Lung Cancer approved by International Association for the Study of Lung Cancer (IASLC) and the American Joint Committee on Cancer (AJCC): IV (Any T, Any N, M1a-c)
* Histologically confirmed NSCLC (adenocarcinoma)
* Performance status of 0-2 (ECOG PS) ○ Estimated life expectancy ≥3 months
* Treatment naïve patients (chemotherapy, immunotherapy, targeted therapy, radiotherapy).
* Smokers or Non-Smokers
* CRC
* Patients diagnosed with the Tumor, Node, Metastasis (TNM) staging system for Colorectal Cancer approved by the American Joint Committee on Cancer (AJCC): IV (Any T, Any N, M1a-c)
* Histologically confirmed CRC (adenocarcinoma)
* Performance status of 0-2 (ECOG PS)
* Estimated life expectancy ≥3 months
* Treatment naïve patients (chemotherapy, immunotherapy, targeted therapy, radiotherapy).
Exclusion Criteria:
* General: History of any other cancer within the previous 5 years, except non-melanoma skin cancer
* General: Absence of Informed consent. \> Pregnant or nursing women. \> Small cell lung cancer.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06997458
Study Brief:
Protocol Section:
NCT06997458